Retrospective analysis of bevacizumab and cetuximab in advanced Asian colorectal cancer patients
Colorectal cancer is a serious health problem that has concerned people for decades. In Hong Kong, it is the most common cancer and the second leading cause of death. Among colorectal cancer patients, around 40-50% of them will develop metastatic disease. Chemotherapy is playing an important role al...
| Main Authors: | , |
|---|---|
| Language: | English |
| Published: |
The University of Hong Kong (Pokfulam, Hong Kong)
2015
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/10722/209506 |